INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression. This investigation was undertaken to determine if tethering affected Nrf2 degradation. Data is presented showing that Nrf2 is degraded by the ubiquitin-proteasome pathway. Nrf2 coimmunoprecipitated with a HA tagged ubiquitin polymer and accumulated in cells expressing inactive ubiquitin activating enzyme El. Inhibition of proteasome activity resulted in accumulation of Nrf2. The rate of Nrf2 degradation, measured under conditions where the majority of Nrf2 was not tethered, exhibited a T 1/2 of approximately 3 h. Over-expression of human INrf2, KIAA0132, blocked Nrf2 conjugation to the ubiquitin polymer and blocked Nrf2 degradation. These results suggest that association of Nrf2 with INrf2 inhibits ubiquitin-proteasome degradation of Nrf2. Maintaining the majority of Nrf2 in a tethered form, resistant to ubiquitin-proteasome dependent degradation, allows a pool of Nrf2 to be available for rapid Nrf2/AREdependent gene transcription following stress mediated release from INrf2. Further, the observation that free Nrf2 is degraded by the ubiquitin proteasome pathway provides a potential mechanism by which ARE-dependent gene transcription is attenuated after induction. Oncogene (2002 Oncogene ( ) 21, 6829 -6834. doi:10.1038 Keywords: Nrf2; INrf2; ubiquitin; proteasome Antioxidant response elements (Favreau and Pickett, 1991; Friling et al., 1990) regulate both basal and inducible expression of many Phase II genes including glutathione S transferases, UDP-glucuronosyltransferase, NAD(P)H:quinone oxidoreductase l, heme oxygenase, catalase and superoxide dismutase (McMahon et al., 2001) . The genes that encode the enzyme gglutamylcysteine synthetase, GCLC and GCLM, also exhibit antioxidant response element (ARE) dependent regulation (Mulcahy et al., 1997) . Identifying the mechanisms by which ARE mediated gene expression is regulated can be important because of their role in chemoprevention strategies (McMahon et al., 2001; Ramos-Gomez et al., 2001; Wolf, 2001) .
Gamma glutamylcysteine synthetase is the rate limiting enzyme for the synthesis of glutathione (GSH). GSH is a soluble intracellular antioxidant that participates in a number of processes including detoxification of peroxides and xenobiotics (Meister and Anderson, 1983) . g-Glutamylcysteine synthetase is a heterodimeric enzyme consisting of a catalytic subunit, Gclc (formerly named Glclc) and a modifying or regulatory subunit, Gclm (formerly named Glclr). In HepG2 cells, inducible expression of GCLC gene is regulated by an antioxidant response element, termed ARE4 (Mulcahy et al., 1997) . Thus, GCLC represents a model for investigating ARE dependent gene expression.
ARE4 dependent GCLC gene expression is regulated, in part, by the Cap 'n' Collar b-zip transcription factor Nrf2 (Chan and Kwong, 2000; Wild et al., 1999) . KIAA0132, the human homolog of rat INrf2 and murine Keap 1, tethers Nrf2 in the cytosol as a result of association with several INrf2 domains (Dhakshinamoorthy and Jaiswal, 2001; Itoh et al., 1999) . In response to oxidative stress, INrf2 releases the tethered Nrf2, which translocates into the nucleus, activating ARE dependent gene transcription (Sekhar et al., 2002) . Therefore, the magnitude of Nrf2-ARE dependent gene transcription will depend, in part, on the cytosolic concentration of Nrf2.
Previous work from our laboratory (Sekhar et al., 2000) has shown that exposure to lactacystin, a 26S proteasome inhibitor, or the amino acid analog azetidine carboxylate, which inhibits proteasome activity as a result of increasing the number of proteins targeted to the proteasome, induced (1) rapid and robust human Nrf2-ARE4 DNA binding activity, (2) ARE4 dependent reporter gene activity, (3) elevation of GCLC mRNA, and (4) a twofold increase in intracellular GSH levels. Such findings suggested that 26S proteasome activity might represent a central regulatory pathway for Nrf2-ARE dependent gene expression. Consistent with these observations, Kwak et al. (2002) recently reported that murine Nrf2 levels were increased by exposure to the proteasome inhibitor MG132.
The 26S proteasome is a multicatalytic protease that exhibits a chymotrypsin-like, trypsin-like, and a peptidyl-glutamyl peptide hydrolyzing activity. The majority of cellular proteins, both long and short lived, are degraded by the proteasome. Most, but not all, proteins destined for proteasome-dependent degradation are recognized as targeted substrates because of the presence of covalently bound ubiquitin multimers (Ciechanover, 1998; Xie and Varshavsky, 2000) . Ubiquitin (Ub) is a small protein (76 amino acids) that is conjugated to substrates in a three step process: activation of Ub by the Ub-activating enzyme E1, transfer to a member of the Ub-protein ligase family (E3) by a member of the Ub-carrier proteins E2 (Ciechanover, 1998) and covalent linkage to the targeted protein by an E3. However, not all proteins require ubiquitination for targeting to the proteasome; examples include ornithine decarboxylase (Murakami et al., 1992) , the transcription factor Sp1 (Su et al., 1999) , and the Cdk inhibitor p21 (Sheaff et al., 2000) . Therefore, this current investigation sought to determine whether Nrf2 was a ubiquitin substrate that underwent subsequent proteasome dependent degradation and whether tethering affected this process.
Nrf2 is a ubiquitin-proteasome substrate
pMT123 is a HA-tagged ubiquitin expression vector (Treier et al., 1994) consisting of a cytomegalovirus (CMV) promoter/enhancer region that regulates the transcription of a message coding for eight contiguous ubiquitin molecules and an amino terminus influenza virus hemagglutinin (HA) epitope tag. HepG2 cells were transiently co-transfected with the ubiquitin expression vector (pMT123) and a vector expressing human Nrf2. Control cells were co-transfected with pMT123 and a vector expressing c-Jun, itself a ubiquitin substrate. Ubiquitinated proteins were immunoprecipitated from solubilized cells using antibody to the HA epitope and then separated by 1D PAGE. Immunoblotting using Nrf2 antibody demonstrated that Nrf2 physically associated with the HA tagged polyubiquitin molecule in vivo ( Figure 1a) . In control cells, the presence of overexpressed c-Jun would be expected to out-compete endogenous Nrf2 for the HA ubiquitin polymer. The absence of a signal in the control lane is consistent with this expectation.
The mouse cell line ts20 contains a temperature sensitive mutation in the Ub-activating enzyme E1 (Chowdary et al., 1994) . The cells exhibit a wild type phenotype at 358C; at the restrictive temperature of 398C E1 activity is inhibited and ubiquitin substrates accumulate (Chowdary et al., 1994) . Figure 1b illustrates an experiment in which ts20 cells were incubated at either 35 or 398C for the indicated intervals. Immuno blotting of total cell lysate ( Figure  1b) , or isolated nuclei (Sekhar et al., 2000) (Figure 1d ) using antibody to Nrf2, indicated that Nrf2 levels increased in cells maintained at 398C and accumulated in nuclei, in contrast to cells maintained at 358C. It should be noted that 35 S methionine labeling of in vitro transcription/translated human Nrf2 results in expression of a polypeptide band with an apparent M r of 100 000 (Moi et al., 1994) and unpublished results. The predicted molecular mass of Nrf2 is 66 000 kDa but it migrates anomalously in 1D PAGE (Moi et al., 1994) . The Santa Cruz antibody used in these experiments recognizes one immuno reactive band at a M r of 100 000 and several bands at and below a M r of 50 000 in murine cells. The 100 000 M r immuno reactive band is shown in Figure 1 .
The data presented in Figure 1 indicates that Nrf2 accumulated under conditions which inhibited the first step (Ub-activating enzyme E1) in the ubiquitin pathway and these results are consistent with data demonstrating ubiquitin conjugation to Nrf2 ( Figure  1b) .
Lactacystin is a specific inhibitor of the 26S proteasome (Fenteany et al., 1995) . Exposure to 5 mM lactacystin caused Nrf2 to accumulate, as demonstrated in the immuno blot of total cell lysate ( Figure 1c ) and in the blot of isolated nuclei (Figure 1d ). Taken together, the data presented in Figure 1 are consistent with Nrf2 being a substrate of the ubiquitin-proteasome pathway. The data also indicate that inhibition of the pathway results in Nrf2 accumulation.
KIAA0132, the Nrf2 cytosolic tether, regulates Nrf2 half life KIAA0132, the human homolog of INrf2 (Dhakshinamoorthy and Jaiswal, 2001), contains a BTB domain and a double glycine repeat (DGR) module (Itoh et al., 1999) . Binding of Nrf2 to INrf2 sequesters it in the cytosol, preventing nuclear localization and gene dependent activity (Dhakshinamoorthy and Jaiswal, 2001; Itoh et al., 1999; Sekhar et al., 2002) . Similar results occur when KIAA0132 is overexpressed in human HepG2 cells (Figure 2a,b) . Figure 2 shows that transient transfection of a FLAG tagged KIAA0132 expression vector resulted in expression of immuno reactive FLAG tagged protein in HepG2 cells, as shown by the Western blot located in the top panel of Figure 2a . Endogenous Nrf2 was found to associate with FLAG tagged KIAA0132 in HepG2 cells, as shown in the lower panel of Figure 2a . Here, cells were transiently transfected with the FLAG tagged KIAA0132 expression vector and then solubilized. FLAG antibody was used to immunoprecipitate protein that was subsequently separated by 1D PAGE, and immunoblotted with antibody to Nrf2 (Figure 2a,  lower panel) .
A functional assay was also used to illustrate KIAA0132 tethering of endogenous Nrf2. A 3924 bp fragment (73678 to +246) from the 5'-flanking promoter sequence of GCLC was cloned from a human BAC library and subcloned into pGL3Basic (Promega), a luciferase reporter vector (pGL3/GCLC; (Sekhar et al., 2002) ). This reporter vector produced a 35-fold increase in luciferase activity when compared to the insertless pGL3/Basic reporter and normalized to beta galactosidase expression (compare activity from pGL3/Basic/insertless to pGL3/GCLC, Figure 2b) . A pGL3/GCLC/ARE4m reporter vector was then constructed such that the Nrf2 DNA binding site in the antioxidant response element (ARE4) (Wild et al., 1999) was mutated so that bases CGCTGAGTCAC were changed to CGCcaAGTCAC (Sekhar et al., 2002; Wild et al., 1998) . This mutation completely abrogated Nrf2 DNA binding activity, as assessed by super shifted EMSA (Sekhar et al., 2000) . The ARE4 mutation significantly decreased pGL3/GCLC/ARE 4 reporter activity relative to the activity produced by pGL3/GCLC and normalized to beta galactosidase expression (P40.05; ANOVA; Figure 2b ). These results suggest that basal expression of GCLC requires a functional ARE4 element to which transcription factors such as Nrf2 can bind.
Transient co-transfection of the INrf2 expression vector (pcDNA3.1/KIAA0132) and pGL3/GCLC significantly diminished luciferase reporter activity compared to transfection of pGL3/GCLC plus insertless pcDNA3.1 (Figure 2b ). The negative regulation of the GCLC promoter by INrf2 was presumably due to its ability to tether Nrf2. Results consistent with this explanation have been obtained by Northern blotting (Figure 5 in Sekhar et al., 2002) . In those experiments, over-expression of INrf2 diminished GCLC mRNA levels. The observations that over expressed INrf2 associated with endogenous Nrf2, (Figure 2a ), diminished GCLC reporter activity (Figure 2b) , and decreased GCLC mRNA levels (Sekhar et al., 2002) suggests that in HepG2 liver cells, expression of basal Nrf2 exceeds the binding capacity of endogenous expressed INrf2 and contributes to basal expression of GCLC. Such an interpretation is consistent with observations that basal expression of GCLC mRNA and protein levels were diminished in fibroblasts (Chan and Kwong, 2000) and livers (Chanas et al., 2002) derived from Nrf2 7/7 mice. Further support for this interpretation is shown in 2C where nuclei were isolated (Sekhar et al., 2000) from HepG2 cells and analysed by immunoblotting using antibody to Nrf2. The immunoblot shown indicates the presence of Nrf2 in HepG2 nuclei. Taken all together, the data presented in Figure 2 indicates that overexpressed KIAA0132 associates with endogenous Nrf2.
To determine if Nrf2 tethering to KIAA0132 affected the ability of Nrf2 to be ubiquitinated, cells were transiently co-transfected with the HA tagged polyubiquitin expression vector, pMT123, a vector expressing Nrf2 and either a vector that expressed Figure 1 Nrf2 is a ubiquitin-proteasome substrate. (a) Nrf2 immunoprecipitates with a HA tagged ubiquitin molecule. HepG2 cells were transiently co-transfected using DMRIE C (Life Sciences) containing 1 mg of the HA tagged ubiquitin expression vector (pMT123; a gracious gift from Dr D Bohmann) and 1 mg of pcDNA1/Nrf2 (a gracious gift from Dr YW Kan). Control cells were co-transfected with 1 mg pMT123 and 1 mg pMT35 (a gracious gift from Dr D Bohmann) which expresses c-Jun. Twenty-four hours after transfection, cells were solubilized in the presence of AEBSF (520 mM), aprotinin (0.4 mM), leupeptin (10.5 mM), bestatin (18 mM), pepstatin A (7.5 mM) and E64 (7 mM) and immuno-precipitated with antibody to the HA epitope (Upstate Biotech), The immunoprecipitate was immunoblotted using antibody to Nrf2 (Santa Cruz # SC-722). (b) Mouse ts20 cells (a gracious gift from Dr HL Ozer), which express a temperature sensitive defect in the ubiquitin enzyme E1, accumulate Nrf2 when held at the non-permissive temperature of 398C. Exponentially growing ts20 cells were incubated at either the permissive temperature of 358C or the non-permissive temperature of 398C for up to 7 h, prior to solubilization. Polypeptides were separated by 1D PAGE and Nrf2 levels determined by immunoblotting. (c) Proteasome inhibition results in Nrf2 accumulation. Cells were incubated in 5 mM lactacystin for up to 11 h prior to solubilization. Polypeptides were separated by 1D PAGE and Nrf2 levels determined by immuno blotting. (d) Accumulation of Nrf2 in the nucleus. Mouse ts20 cells were incubated at 35 or 398C for the indicated times, prior to isolation of nuclei, as described by (Sekhar et al., 2000) , or cells were incubated for 8 h at 358C in the absence or presence of 5 mM lactacystin prior to isolation of nuclei KIAA0132 or insertless vector. Thirty-six hours after transfection, cells were solubilized, and protein immunoprecipitated with antibody to the HA epitope of the polyubiquitin molecule. The precipitate was immunoblotted with antibody to Nrf2 (Figure 2d ). The data presented in Figure 2 show that ectopic expression of KIAA0132 decreased the ubiquitination of Nrf2. This indicates that tethering of Nrf2 to KIAA0132 prevents ubiquitination and suggests that tethering of Nrf2 may shield it from association with an E3 Ub ligase molecule.
Ubiquitination of proteins, in most cases, can lead to rapid proteasome dependent degradation. However, it can also produce rapid activation, as in the case of TRAF6 (Wang et al., 2001) . Therefore, half life of Nrf2 was measured in the absence or presence of ectopically expressed KIAA0132 (Figure 3) . Figure 3a illustrates a representative experiment, while Figure 3b represents the mean (+s.d.) of three experiments. Under these experimental conditions, the half life of Nr2 was calculated to be 3 h. Ectopic over-expression of KIAA0132 stabilized Nrf2, preventing its degradation over the experimental time course.
The work presented in this current investigation has shown that Nrf2 is a substrate for the ubiquitin proteasome pathway. This conclusion is based on the following observations: (1) Immunoprecipitation of a transfected ubiquitin polymer co-precipitated Nrf2; (2) Incubation of a mutant ts20 cell line at the nonpermissive temperature of 398C which inactivates the ubiquitin activating enzyme E1 (Chowdary et al., 1994) , resulted in Nrf2 accumulation; (3) Inhibition of 26S proteasome function using lactacystin resulted in Nrf2 accumulation (Figure 1 and Kwak et al., 2002) . These novel results complement our previous work which has shown that inhibition of proteasome function increased the DNA binding activity of human Nrf2, demonstrated using an ARE4 oligomer in a gel mobility shift assay competed with Nrf2 antibody. In addition, proteasome inhibition was found to induce ARE4 dependent reporter gene activity, increase GCLC mRNA levels, and increase GSH concentra- (Sekhar et al., 2002) . A cDNA encoding KIAA0132 was a gracious gift from Dr T Nagase. After transfection, cells were solubilized. Protein was then separated by 1D PAGE, and immunoblotted with FLAG monoclonal antibody (Abcam; upper panel) or protein was immunoprecipitated with FLAG monoclonal antibody, separated by 1D PAGE and immunoblotted using Nrf2 antibody (lower panel). Immunoblots were visualized by chemiluminescence using horseradish peroxidase coupled to secondary antibody (Amersham). (b) HepG2 cells were co-transfected with 0.2 mg of pcDNA3.1/LacZ, and either 0.1 mg of insertless pGL3/Basic, pGL3/GCLC or pGL3/GCLC/ARE4 m . In addition, 2 mg of insertless pcDNA3.1 or pcDNA3.1/KIAA0132 (INrf2) were also transfected into cells. Twenty-four hours after transfection, cells were harvested, luciferase activity determined in triplicate and normalized for b-galactosidase expression. Statistical analysis was by ANOVA. (c) Nuclei were isolated from HepG2 cells, as described by Sekhar et al. (2000) and polypeptides Western blotted with antibody to Nrf2. (d) HepG2 cells were co-transfected with 0.5 mg of a vector expressing HA tagged ubiquitin polymer, 0.5 mg of a Nrf2 expression vector, and either 1 mg of pcDNA3.1 expressing KIAA0132 or 1 mg of pcDNA3.1 empty vector. Thirty-six hours after transfection cells were solubilized and immunoprecipitated with antibody to HA. The immunoprecipitate was fractionated by 1D PAGE and immunoblotted using antibody to Nrf2 tions (Sekhar et al., 2000) . Taken all together, these results suggest that Nrf2 can be targeted for ubiquitination and proteasome dependent degradation, a process inhibited by binding to INrf2.
Work by Itoh et al. (1999) and Dhakshinamoorthy and Jaiswal (2001) has shown that INrf2 tethers Nrf2 in the cytosol while non-tethered Nrf2 can migrate to the nucleus and direct ARE-dependent gene expression. This investigation has shown that INrf2 tethering of Nrf2 blocked ubiquitin-proteasome dependent degradation. Based on the data provided in this current investigation, we hypothesize that in HepG2 cells, Nrf2 levels exceed that of INrf2 and direct basal AREdependent gene expression. This is based on the observation that immunoreactive Nrf2 was found in HepG2 nuclei and that over-expression of KIAA0132 inhibited an ARE-dependent GCLC reporter vector (Figure 2) . The observation that free Nrf2 has a half life of approximately 3 h suggests that the ubiquitin proteasome pathway provides a mechanism for attenuation of basal ARE-dependent gene expression. However, maintaining Nrf2 in a tethered form that is resistant to ubiquitin-proteasome degradation provides a pool of Nrf2, available for immediate Nrf2/AREdependent gene transcription when cells were exposed to stress. Such a mechanism of regulation would eliminate the need for continuous high levels of Nrf2 synthesis. S methionine in methionine free medium. Cells were then washed, non-radioactive growth medium was added back to the cells, which were then incubated at 378C for up to 7 h prior to solubilization and immunoprecipitation with antibody to HA. Nrf2 levels were resolved by 1D PAGE, visualized by fluorography and then quantitated by densitometry. The M r of immunoprecipitated HA Nrf2 was authenticated by comparison with the M r of in vitro transcribed/translated HA Nrf2 (data not shown)
